IDEAYA Biosciences Inc at Goldman Sachs Healthcare Conference Transcript
For our last session of the day, thanks so much to the team from IDEAYA Biosciences for joining us. Maybe just quickly an introduction from both of you. And if you could, a brief overview (technical difficulty) today and with respect to what your value drivers are.
Sure. Well, first, thank you so much, Karen, for the kind invitation to participate this year. Yujiro Hata, President and CEO. I can maybe let Darrin do a quick introduction as well, and I'm happy to go through a quick overview.
Yeah. Hi, I am Darrin Beaupre. I'm the Chief Medical Officer at IDEAYA Biosciences. I've been with the company for about seven or eight months now. My background is I'm a medical oncologist, hematologist, PhD in cancer biology. Started out at the Moffitt Cancer Center, but I've been in the industry 16 years. Joined IDEAYA because of an amazing pipeline that you're going to hear about.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
